FONAR Corporation (FONR)
USD 12.36
(-1.59%)
USD 12.36
(-1.59%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 37.92 Million USD | -41.83% |
| 2023 | 32.84 Million USD | -3.65% |
| 2022 | 34.08 Million USD | 10.72% |
| 2021 | 30.78 Million USD | -4.46% |
| 2020 | 32.22 Million USD | 11697.74% |
| 2019 | 273.11 Thousand USD | -10.76% |
| 2018 | 306.03 Thousand USD | -9.12% |
| 2017 | 336.76 Thousand USD | -83.65% |
| 2016 | 2.05 Million USD | -63.87% |
| 2015 | 5.69 Million USD | -32.81% |
| 2014 | 8.48 Million USD | -34.18% |
| 2013 | 12.88 Million USD | 1557.97% |
| 2012 | 777.27 Thousand USD | -55.49% |
| 2011 | 1.74 Million USD | 6.55% |
| 2010 | 1.63 Million USD | 78.27% |
| 2009 | 919.38 Thousand USD | 21.46% |
| 2008 | 756.97 Thousand USD | -20.78% |
| 2007 | 955.56 Thousand USD | -18.46% |
| 2006 | 1.17 Million USD | 21.27% |
| 2005 | 966.37 Thousand USD | 34.31% |
| 2004 | 719.5 Thousand USD | -20.73% |
| 2003 | 907.62 Thousand USD | 8.94% |
| 2002 | 833.16 Thousand USD | -91.76% |
| 2001 | 10.1 Million USD | -31.44% |
| 2000 | 14.74 Million USD | -27.37% |
| 1999 | 20.3 Million USD | 49.26% |
| 1998 | 13.6 Million USD | 655.56% |
| 1997 | 1.8 Million USD | 80.0% |
| 1996 | 1 Million USD | 100.0% |
| 1995 | 500 Thousand USD | -66.67% |
| 1994 | 1.5 Million USD | -50.0% |
| 1993 | 3 Million USD | -58.33% |
| 1992 | 7.2 Million USD | -1.37% |
| 1991 | 7.3 Million USD | -23.96% |
| 1990 | 9.6 Million USD | -21.31% |
| 1989 | 12.2 Million USD | 125.93% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 80 Thousand USD | -13.04% |
| 2024 Q2 | 30.89 Million USD | -11.54% |
| 2024 Q1 | 32.17 Million USD | -9.62% |
| 2024 Q4 | 37.92 Million USD | -16.33% |
| 2023 Q4 | 32.84 Million USD | -1.71% |
| 2023 FY | 32.84 Million USD | -3.65% |
| 2023 Q1 | 34.04 Million USD | -0.12% |
| 2023 Q2 | 34 Million USD | -0.12% |
| 2023 Q3 | 33.41 Million USD | -1.74% |
| 2022 Q4 | 34.08 Million USD | -1.83% |
| 2022 Q1 | 29.47 Million USD | -4.24% |
| 2022 Q2 | 34.8 Million USD | 18.07% |
| 2022 Q3 | 34.72 Million USD | -0.24% |
| 2022 FY | 34.08 Million USD | 10.72% |
| 2021 Q4 | 30.78 Million USD | 2.08% |
| 2021 Q3 | 30.15 Million USD | -0.62% |
| 2021 Q2 | 30.34 Million USD | -3.07% |
| 2021 Q1 | 31.3 Million USD | -2.84% |
| 2021 FY | 30.78 Million USD | -4.46% |
| 2020 Q2 | 28.93 Million USD | -2.74% |
| 2020 Q3 | 28.13 Million USD | -2.79% |
| 2020 Q4 | 32.22 Million USD | 14.54% |
| 2020 Q1 | 29.75 Million USD | 10794.07% |
| 2020 FY | 32.22 Million USD | 11697.74% |
| 2019 Q4 | 273.11 Thousand USD | -3.15% |
| 2019 FY | 273.11 Thousand USD | -10.76% |
| 2019 Q1 | 298 Thousand USD | -2.63% |
| 2019 Q2 | 290 Thousand USD | -2.68% |
| 2019 Q3 | 282 Thousand USD | -2.76% |
| 2018 Q1 | 329 Thousand USD | -2.3% |
| 2018 Q4 | 306.03 Thousand USD | -2.85% |
| 2018 Q3 | 315 Thousand USD | -2.48% |
| 2018 Q2 | 323 Thousand USD | -1.82% |
| 2018 FY | 306.03 Thousand USD | -9.12% |
| 2017 Q1 | 661 Thousand USD | -67.9% |
| 2017 Q2 | 411 Thousand USD | -37.82% |
| 2017 FY | 336.76 Thousand USD | -83.65% |
| 2017 Q4 | 336.76 Thousand USD | -3.23% |
| 2017 Q3 | 348 Thousand USD | -15.33% |
| 2016 FY | 2.05 Million USD | -63.87% |
| 2016 Q1 | 5.08 Million USD | -10.73% |
| 2016 Q4 | 2.05 Million USD | -46.69% |
| 2016 Q2 | 4.47 Million USD | -12.05% |
| 2016 Q3 | 3.86 Million USD | -13.68% |
| 2015 FY | 5.69 Million USD | -32.81% |
| 2015 Q2 | 6.93 Million USD | -8.26% |
| 2015 Q3 | 6.31 Million USD | -9.0% |
| 2015 Q1 | 7.55 Million USD | -10.88% |
| 2015 Q4 | 5.69 Million USD | -9.69% |
| 2014 FY | 8.48 Million USD | -34.18% |
| 2014 Q4 | 8.48 Million USD | -9.81% |
| 2014 Q2 | 10.53 Million USD | -9.61% |
| 2014 Q1 | 11.64 Million USD | -9.61% |
| 2014 Q3 | 9.4 Million USD | -10.69% |
| 2013 Q2 | 634 Thousand USD | -10.2% |
| 2013 Q3 | 13.4 Million USD | 2014.2% |
| 2013 Q4 | 12.88 Million USD | -3.86% |
| 2013 FY | 12.88 Million USD | 1557.97% |
| 2013 Q1 | 706 Thousand USD | -9.17% |
| 2012 Q1 | 1.62 Million USD | -6.77% |
| 2012 Q2 | 1.49 Million USD | -8.48% |
| 2012 Q3 | 1.04 Million USD | -29.66% |
| 2012 Q4 | 777.27 Thousand USD | -25.83% |
| 2012 FY | 777.27 Thousand USD | -55.49% |
| 2011 FY | 1.74 Million USD | 6.55% |
| 2011 Q4 | 1.74 Million USD | -11.89% |
| 2011 Q3 | 1.98 Million USD | 3.99% |
| 2011 Q2 | 1.9 Million USD | 12.18% |
| 2011 Q1 | 1.69 Million USD | 3.66% |
| 2010 Q4 | 1.63 Million USD | -15.78% |
| 2010 Q3 | 1.94 Million USD | 143.55% |
| 2010 Q2 | 799 Thousand USD | -47.71% |
| 2010 Q1 | 1.52 Million USD | 66.2% |
| 2010 FY | 1.63 Million USD | 78.27% |
| 2009 Q1 | 1.36 Million USD | 80.59% |
| 2009 Q4 | 919.38 Thousand USD | 9.32% |
| 2009 FY | 919.38 Thousand USD | 21.46% |
| 2009 Q2 | 875 Thousand USD | -35.99% |
| 2009 Q3 | 841 Thousand USD | -3.89% |
| 2008 Q2 | 850 Thousand USD | -5.66% |
| 2008 Q1 | 901 Thousand USD | -5.71% |
| 2008 Q3 | 805 Thousand USD | -5.29% |
| 2008 Q4 | 756.97 Thousand USD | -5.97% |
| 2008 FY | 756.97 Thousand USD | -20.78% |
| 2007 Q3 | 1.01 Million USD | -5.24% |
| 2007 Q2 | 1.06 Million USD | -4.81% |
| 2007 Q1 | 1.12 Million USD | -4.26% |
| 2007 Q4 | 955.56 Thousand USD | -5.58% |
| 2007 FY | 955.56 Thousand USD | -18.46% |
| 2006 Q3 | 1.14 Million USD | -9.86% |
| 2006 Q4 | 1.17 Million USD | 2.53% |
| 2006 FY | 1.17 Million USD | 21.27% |
| 2006 Q1 | 983 Thousand USD | 1.72% |
| 2006 Q2 | 1.26 Million USD | 28.99% |
| 2005 Q3 | 494 Thousand USD | -12.26% |
| 2005 FY | 966.37 Thousand USD | 34.31% |
| 2005 Q4 | 966.37 Thousand USD | 95.62% |
| 2005 Q2 | 563 Thousand USD | -11.89% |
| 2005 Q1 | 639 Thousand USD | -11.19% |
| 2004 Q4 | 719.5 Thousand USD | -8.58% |
| 2004 FY | 719.5 Thousand USD | -20.73% |
| 2004 Q1 | 1.06 Million USD | 17.23% |
| 2004 Q2 | 782 Thousand USD | -26.5% |
| 2004 Q3 | 787 Thousand USD | 0.64% |
| 2003 FY | 907.62 Thousand USD | 8.94% |
| 2003 Q4 | 907.62 Thousand USD | -8.41% |
| 2003 Q1 | 450 Thousand USD | -45.99% |
| 2003 Q2 | 333 Thousand USD | -26.0% |
| 2003 Q3 | 991 Thousand USD | 197.6% |
| 2002 Q1 | 8.77 Million USD | -13.17% |
| 2002 Q2 | 7.64 Million USD | -12.93% |
| 2002 Q4 | 833.16 Thousand USD | -87.86% |
| 2002 Q3 | 6.86 Million USD | -10.22% |
| 2002 FY | 833.16 Thousand USD | -91.76% |
| 2001 Q3 | 10.74 Million USD | -12.61% |
| 2001 Q4 | 10.1 Million USD | -5.91% |
| 2001 FY | 10.1 Million USD | -31.44% |
| 2001 Q2 | 12.29 Million USD | -4.82% |
| 2001 Q1 | 12.91 Million USD | -12.39% |
| 2000 FY | 14.74 Million USD | -27.37% |
| 2000 Q4 | 14.74 Million USD | -15.39% |
| 2000 Q3 | 17.42 Million USD | -4.77% |
| 2000 Q2 | 18.3 Million USD | -3.17% |
| 2000 Q1 | 18.9 Million USD | -6.9% |
| 1999 Q3 | 20.9 Million USD | 1.46% |
| 1999 Q1 | 20.6 Million USD | 51.47% |
| 1999 FY | 20.3 Million USD | 49.26% |
| 1999 Q4 | 20.3 Million USD | -2.87% |
| 1999 Q2 | 20.6 Million USD | 0.0% |
| 1998 Q4 | 13.6 Million USD | 47.83% |
| 1998 FY | 13.6 Million USD | 655.56% |
| 1998 Q1 | 1.9 Million USD | 5.56% |
| 1998 Q2 | 2.2 Million USD | 15.79% |
| 1998 Q3 | 9.2 Million USD | 318.18% |
| 1997 Q2 | 700 Thousand USD | -12.5% |
| 1997 Q4 | 1.8 Million USD | 125.0% |
| 1997 Q1 | 800 Thousand USD | -20.0% |
| 1997 Q3 | 800 Thousand USD | 14.29% |
| 1997 FY | 1.8 Million USD | 80.0% |
| 1996 Q1 | 500 Thousand USD | 0.0% |
| 1996 FY | 1 Million USD | 100.0% |
| 1996 Q4 | 1 Million USD | 25.0% |
| 1996 Q3 | 800 Thousand USD | 0.0% |
| 1996 Q2 | 800 Thousand USD | 60.0% |
| 1995 Q2 | 1.2 Million USD | -7.69% |
| 1995 Q1 | 1.3 Million USD | -13.33% |
| 1995 Q3 | 1 Million USD | -16.67% |
| 1995 Q4 | 500 Thousand USD | -50.0% |
| 1995 FY | 500 Thousand USD | -66.67% |
| 1994 Q4 | 1.5 Million USD | -25.0% |
| 1994 FY | 1.5 Million USD | -50.0% |
| 1994 Q3 | 2 Million USD | -23.08% |
| 1994 Q1 | 3 Million USD | 0.0% |
| 1994 Q2 | 2.6 Million USD | -13.33% |
| 1993 Q1 | 6.6 Million USD | -8.33% |
| 1993 Q2 | 6 Million USD | -9.09% |
| 1993 Q3 | 5.5 Million USD | -8.33% |
| 1993 Q4 | 3 Million USD | -45.45% |
| 1993 FY | 3 Million USD | -58.33% |
| 1992 Q3 | 5.5 Million USD | -1.79% |
| 1992 FY | 7.2 Million USD | -1.37% |
| 1992 Q1 | 6.6 Million USD | -9.59% |
| 1992 Q2 | 5.6 Million USD | -15.15% |
| 1992 Q4 | 7.2 Million USD | 30.91% |
| 1991 Q1 | 8.3 Million USD | -13.54% |
| 1991 Q4 | 7.3 Million USD | -14.12% |
| 1991 Q2 | 7.5 Million USD | -9.64% |
| 1991 FY | 7.3 Million USD | -23.96% |
| 1991 Q3 | 8.5 Million USD | 13.33% |
| 1990 Q4 | 9.6 Million USD | -4.95% |
| 1990 Q3 | 10.1 Million USD | -0.98% |
| 1990 FY | 9.6 Million USD | -21.31% |
| 1990 Q2 | 10.2 Million USD | 0.0% |
| 1989 FY | 12.2 Million USD | 125.93% |
| 1989 Q4 | 12.2 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -5.062% |
| Sight Sciences, Inc. | 31.7 Million USD | -19.621% |
| TELA Bio, Inc. | 40.51 Million USD | 6.382% |
| Acutus Medical, Inc. | 32.65 Million USD | -16.155% |
| Talis Biomedical Corporation | 16.78 Million USD | -125.959% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -3629.795% |
| Bioventus Inc. | 366.99 Million USD | 89.665% |
| BrainsWay Ltd. | 239 Thousand USD | -15770.045% |
| Envoy Medical, Inc. | 404 Thousand USD | -9288.467% |
| CVRx, Inc. | 30.38 Million USD | -24.842% |
| electroCore, Inc. | 537 Thousand USD | -6963.204% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -68508.29% |
| Orthofix Medical Inc. | 93.1 Million USD | 59.263% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -315978.392% |
| IceCure Medical Ltd | 376 Thousand USD | -9987.608% |
| Inogen, Inc. | 18.27 Million USD | -107.605% |
| OrthoPediatrics Corp. | 13.45 Million USD | -181.814% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -18960.004% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -10328.074% |
| MaxCyte, Inc. | 17.96 Million USD | -111.082% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -837.686% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| PAVmed Inc | 2.96 Million USD | -1181.399% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -510.386% |
| RxSight, Inc. | 1.21 Million USD | -3032.073% |
| SI-BONE, Inc. | 36.06 Million USD | -5.17% |
| Treace Medical Concepts, Inc. | 53 Million USD | 28.446% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -2393.715% |
| Cerus Corporation | 59.79 Million USD | 36.569% |
| Venus Concept Inc. | 70.79 Million USD | 46.42% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -2948.988% |
| LivaNova PLC | 568.54 Million USD | 93.329% |
| 908 Devices Inc. | 3.92 Million USD | -865.371% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 92.578% |
| Nemaura Medical Inc. | 3.08 Million USD | -1128.423% |
| NeuroPace, Inc. | 56.95 Million USD | 33.403% |
| LENSAR, Inc. | 1.75 Million USD | -2067.395% |
| Apyx Medical Corporation | 33.18 Million USD | -14.297% |
| Cutera, Inc. | 418.69 Million USD | 90.941% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -152.123% |
| BioSig Technologies, Inc. | 103 Thousand USD | -36724.667% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -40.981% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -281.238% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 97.446% |
| Axonics, Inc. | 25.84 Million USD | -46.786% |
| Outset Medical, Inc. | 134.59 Million USD | 71.82% |
| IRIDEX Corporation | 1.75 Million USD | -2066.157% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 26.12% |
| IRadimed Corporation | 1.61 Million USD | -2248.454% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -21450.799% |
| INVO Bioscience, Inc. | 6.77 Million USD | -459.754% |
| Telesis Bio, Inc. | 5.26 Million USD | -619.86% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -535.196% |
| Varex Imaging Corporation | 464.2 Million USD | 91.829% |
| Quipt Home Medical Corp. | 60.82 Million USD | 37.638% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -6350.579% |
| Pulmonx Corporation | 35.08 Million USD | -8.095% |
| Dynatronics Corporation | 3.25 Million USD | -1064.022% |
| Modular Medical, Inc. | 817 Thousand USD | -4542.522% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -25018.813% |
| Semler Scientific, Inc. | 70 Thousand USD | -54084.867% |
| InMode Ltd. | 6.61 Million USD | -473.558% |
| Bruker Corporation | 1.14 Billion USD | 96.686% |
| Cytosorbents Corporation | 2.54 Million USD | -1391.606% |
| DexCom, Inc. | 2.57 Billion USD | 98.526% |
| Align Technology, Inc. | 96.96 Million USD | 60.885% |
| Viveve Medical, Inc. | 5.12 Million USD | -640.23% |
| ZimVie Inc. | 508.79 Million USD | 92.545% |
| Movano Inc. | 15.00 USD | -252862613.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -109.266% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 90.485% |
| Profound Medical Corp. | 4.97 Million USD | -662.489% |
| Insulet Corporation | 1.36 Billion USD | 97.224% |
| enVVeno Medical Corporation | 1.06 Million USD | -3464.794% |
| Surmodics, Inc. | 29.4 Million USD | -28.99% |
| iCAD, Inc. | 273 Thousand USD | -13793.556% |
| Nuwellis, Inc. | 221 Thousand USD | -17062.628% |
| Biotricity, Inc. | 10.85 Million USD | -249.392% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -8.525% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -5737.53% |
| InspireMD, Inc. | 1.03 Million USD | -3554.085% |
| PAVmed Inc. | 2.96 Million USD | -1181.399% |
| BIOLASE, Inc. | 13.98 Million USD | -171.215% |
| Beyond Air, Inc. | 14.72 Million USD | -157.655% |
| AxoGen, Inc. | 46.6 Million USD | 18.612% |
| Vivani Medical, Inc. | 19.31 Million USD | -96.393% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 14.979% |
| Inari Medical, Inc. | 30.35 Million USD | -24.953% |
| UFP Technologies, Inc. | 28 Million USD | -35.462% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -8638.589% |
| Tenon Medical, Inc. | 428 Thousand USD | -8762.011% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -3685.37% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -1662.372% |
| AdaptHealth Corp. | 2.09 Billion USD | 98.189% |
| Sintx Technologies, Inc. | 3.68 Million USD | -928.734% |
| Quanterix Corporation | 37.22 Million USD | -1.898% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -6350.579% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -6263.994% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 95.749% |
| TransMedics Group, Inc. | 506.2 Million USD | 92.507% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -6148.667% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -40911.415% |
| Hyperfine, Inc. | 64 Thousand USD | -59164.698% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 79.904% |
| Biomerica, Inc. | 459 Thousand USD | -8163.487% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -8338.452% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -19864.212% |
| Silk Road Medical, Inc | 75.62 Million USD | 49.846% |